 |
 |
 |
|
Efficacy and Safety of B/F/TAF in Black Adults With HIV Who
Are Treatment Naïve: 5-Year Follow-Up From Two Phase 3 Studies
|
|
|
ID Week 2024 Oct 16-19 LA, CA
Anson Wurapa1, Yazdan Yazdanpanah2, Chloe Orkin3, Hui Liu4, Rachel Rogers4, David Malebranche4, Jason T Hindman4, Debbie Hagins5
1Infectious Disease Specialists of Atlanta, Decatur, GA, USA; 2Bichat-Claude Bernard Hospital, APHP, Paris, Īle-de-France, France; 3Queen Mary University, London, UK; 4Gilead Sciences, Inc., Foster City, CA, USA; 5Chatham CARE Center, Savannah, GA.







|
|
|
 |
 |
|
|